Literature DB >> 9123698

Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant.

R A Janknegt1, E H Weil, P H Eerdmans.   

Abstract

OBJECTIVES: Neuromodulation is a new technique that uses electrical stimulation of the sacral nerves for patients with refractory urinary urge/frequency or urge-incontinence, and some forms of urinary retention. The limiting factor for receiving an implant is often a failure of the percutaneous nerve evaluation (PNE) test. Present publications mention only about a 50% success score for PNE of all patients, although the micturition diaries and urodynamic parameters are similar. We wanted to investigate whether PNE results improved by using a permanent electrode as a PNE test. This would show that improvement of the PNE technique is feasible.
METHODS: In 10 patients where the original PNE had failed to improve the micturition diary parameters more than 50%, a permanent electrode was implanted by operation. It was connected to an external stimulator. In those cases where the patients improved according to their micturition diary by more than 50% during a period of 4 days, the external stimulator was replaced by a permanent subcutaneous neurostimulator.
RESULTS: Eight of the 10 patients had a good to very good result (60% to 90% improvement) during the testing period and received their implant 5 to 14 days after the first stage.
CONCLUSIONS: The good results of the two-stage implant technique we used indicate that the development of better PNE electrodes may lead to an improvement of the testing technique and better selection between nonresponders and technical failures.

Entities:  

Mesh:

Year:  1997        PMID: 9123698     DOI: 10.1016/S0090-4295(96)00506-7

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  27 in total

1.  The role of electrodiagnostic techniques in the reprogramming of patients with a delayed suboptimal response to sacral nerve stimulation.

Authors:  Mary T McLennan
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-03-12

2.  Helping patients with voiding dysfunction: What are our current options?

Authors:  Kurt A McCammon
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

3.  Neuromodulation for the treatment of refractory interstitial cystitis.

Authors:  Kenneth M Peters
Journal:  Rev Urol       Date:  2002

4.  Sacral nerve stimulation for the management of voiding dysfunction.

Authors:  A K Das; M D White; P A Longhurst
Journal:  Rev Urol       Date:  2000

5.  Comparison of patients undergoing a two-stage sacral nerve stimulation procedure: is there a cost benefit for a single-stage procedure?

Authors:  Dmitriy Nikolavsky; Kim Killinger; Judith Boura; Kenneth Peters
Journal:  Int Urol Nephrol       Date:  2011-03-10       Impact factor: 2.370

Review 6.  How does sacral modulation work best? Placement and programming techniques to maximize efficacy.

Authors:  Bastian Amend; Mahmoud Khalil; Thomas M Kessler; Karl-Dietrich Sievert
Journal:  Curr Urol Rep       Date:  2011-10       Impact factor: 3.092

7.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction.

Authors:  Kari Bo; Helena C Frawley; Bernard T Haylen; Yoram Abramov; Fernando G Almeida; Bary Berghmans; Maria Bortolini; Chantale Dumoulin; Mario Gomes; Doreen McClurg; Jane Meijlink; Elizabeth Shelly; Emanuel Trabuco; Carolina Walker; Amanda Wells
Journal:  Int Urogynecol J       Date:  2016-12-05       Impact factor: 2.894

Review 8.  Fowler's syndrome--a cause of unexplained urinary retention in young women?

Authors:  Nadir I Osman; Christopher R Chapple
Journal:  Nat Rev Urol       Date:  2013-12-10       Impact factor: 14.432

Review 9.  Contrasting the percutaneous nerve evaluation versus staged implantation in sacral neuromodulation.

Authors:  Chad Baxter; Ja-Hong Kim
Journal:  Curr Urol Rep       Date:  2010-09       Impact factor: 3.092

10.  Sacral neuromodulation: Therapy evolution.

Authors:  Jannah H Thompson; Suzette E Sutherland; Steven W Siegel
Journal:  Indian J Urol       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.